Get the Stockscreener App
105.80
0.36%
0.375
After Hours:
105.80
Lemaitre Vascular Inc stock is traded at $105.80, with a volume of 85,636.
It is up +0.36% in the last 24 hours and up +23.54% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
See More
Previous Close:
$105.42
Open:
$106.16
24h Volume:
85,636
Relative Volume:
0.75
Market Cap:
$2.36B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
87.44
EPS:
1.21
Net Cash Flow:
$33.49M
1W Performance:
+2.28%
1M Performance:
+23.54%
6M Performance:
+32.66%
1Y Performance:
+98.31%
1-Day Range:
$104.83
$106.60
1-Week Range:
$102.94
$109.58
52-Week Range:
$51.70
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
105.80 | 2.36B | 213.03M | 41.32M | 33.49M | 1.21 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular - Benzinga
LeMaitre To Participate At Upcoming Investor Conferences In December - Barchart
LeMaitre to Participate at Upcoming Investor Conferences in December - GlobeNewswire
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today? - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Lowered to Hold Rating by StockNews.com - Defense World
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings - Simply Wall St
When the Price of (LMAT) Talks, People Listen - Stock Traders Daily
Victory Capital Management Inc. Acquires 10,011 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Insider Selling: Lawrence Jasinski Sells Shares of LeMaitre Vasc - GuruFocus.com
LeMaitre Vascular stock soars to all-time high of $106.78 By Investing.com - Investing.com South Africa
LeMaitre Vascular stock soars to all-time high of $106.78 - Investing.com India
Bridget Ross At LeMaitre Vascular Decides to Exercises Options Worth $276K - Benzinga
Oppenheimer Asset Management Inc. Cuts Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Ex-Dividend Reminder: LeMaitre Vascular, Discover Financial Services and Bgc Group - Nasdaq
Atria Investments Inc Acquires 2,701 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular director Shadan Martha sells $151,547 in stock - Investing.com
(LMAT) Technical Data - Stock Traders Daily
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Raised by Los Angeles Capital Management LLC - MarketBeat
LMATLeMaitre Vascular, Inc. Latest Stock News & Market Updates - StockTitan
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year HighShould You Buy? - MarketBeat
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular stock soars to all-time high of $104.33 By Investing.com - Investing.com Australia
Portside Wealth Group LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular stock soars to all-time high of $104.33 - Investing.com India
500: Something went wrong - Investing.com
LeMaitre Vascular Inc (LMAT) Quarterly 10-Q Report - Quartzy
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India
(01/18/21) Top Picks 2021: Avid Technology (AVID) and LeMaitre Vascular (LM - Moneyshow.com
Harbor Capital Advisors Inc. Buys 12,797 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
FY2024 EPS Forecast for LeMaitre Vascular Lifted by Analyst - MarketBeat
LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Receives "Outperform" Rating from Oppenheimer - MarketBeat
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion - Investing.com
LeMaitre Vascular Inc (LMAT) Trading 12.71% Higher on Nov 1 - GuruFocus.com
Barrington Research Raises LeMaitre Vascular (NASDAQ:LMAT) Price Target to $93.00 - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular - Benzinga
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Sets New 52-Week High After Strong Earnings - MarketBeat
LeMaitre Vascular stock target upgraded, keeps buy rating on strong Q3 results - Investing.com UK
Conestoga Capital Advisors LLC Purchases 36,850 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):